Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Altisent

Showing results (21-30 of 58) with videos related to

Pageof 6
Sort By:
Thrombosis and Haemostasis|July 15, 2000
Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis CS Sauleda, J I Esteban, C Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2016
Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European surveyJ Windyga, G Dolan, C Altisent, et al.
Seminars in Hematology|December 6, 2001
Recombinant factor VIIa (Novoseven) restores deficient coagulation: experience from an ex vivo modelA M Galán, R Tonda, C Altisent, et al.
Intervirology|January 24, 2002
Prevalence and genetic heterogeneity of the reverse transcriptase T69S-S-X insertion in pretreated HIV-infected patientsC Briones, A Mas, M Pérez-Olmeda, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 21, 2012
Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: a 10-year follow-up studyJ Pardos-Gea, C Altisent, R Parra, et al.
Thrombosis and Haemostasis|July 1, 1996
Inhibitor development in haemophilia A patients with inversion of the intron 22 of the factor VIII geneE F Tizzano, C Altisent, M Domènech, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 25, 2015
Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European surveyJ Windyga, G Dolan, C Altisent, et al.
AIDS (London, England)|April 10, 1999
V3-loop and nef gene sequences of HIV-1 isolates from a hemophiliac cohort with long-term non-progressive infectionA Vallejo, A Mas, A Heredia, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitorJ B Montoro, C Altisent, M Pico, et al.
Hepatology (Baltimore, Md.)|October 27, 2001
Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disordersS Sauleda, A Juárez, J I Esteban, et al.
Pageof 6

Showing results (21-30 of 58) with videos related to

Sort By:
Pageof 6
Thrombosis and Haemostasis|July 15, 2000
Treatment with interferon plus ribavirin in anti-HIV negative patients with congenital coagulation disorders and chronic hepatitis CS Sauleda, J I Esteban, C Altisent, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 14, 2016
Practical aspects of factor concentrate use in patients with von Willebrand disease undergoing invasive procedures: a European surveyJ Windyga, G Dolan, C Altisent, et al.
Seminars in Hematology|December 6, 2001
Recombinant factor VIIa (Novoseven) restores deficient coagulation: experience from an ex vivo modelA M Galán, R Tonda, C Altisent, et al.
Intervirology|January 24, 2002
Prevalence and genetic heterogeneity of the reverse transcriptase T69S-S-X insertion in pretreated HIV-infected patientsC Briones, A Mas, M Pérez-Olmeda, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 21, 2012
Acquired haemophilia A. First line treatment with calcineurin inhibitors and steroid pulses: a 10-year follow-up studyJ Pardos-Gea, C Altisent, R Parra, et al.
Thrombosis and Haemostasis|July 1, 1996
Inhibitor development in haemophilia A patients with inversion of the intron 22 of the factor VIII geneE F Tizzano, C Altisent, M Domènech, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 25, 2015
Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European surveyJ Windyga, G Dolan, C Altisent, et al.
AIDS (London, England)|April 10, 1999
V3-loop and nef gene sequences of HIV-1 isolates from a hemophiliac cohort with long-term non-progressive infectionA Vallejo, A Mas, A Heredia, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 5, 1999
Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitorJ B Montoro, C Altisent, M Pico, et al.
Hepatology (Baltimore, Md.)|October 27, 2001
Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disordersS Sauleda, A Juárez, J I Esteban, et al.
Pageof 6